Cerecin is an emerging company with a portfolio focused on developing new treatments for the central nervous system, including migraine, and it recently established its Australian corporate presence. …
Emerging Cerecin looking to build its Australian presence
September 21, 2020 Latest NewsBioPharmaDispatch Executive
Latest Video
New Stories
-
The COVID-19 vaccine manufacturing and supply deals
October 21, 2020 - - Latest News -
CSL 'on track' to commence manufacture of AZ vaccine in November
October 21, 2020 - - Latest News -
Services Australia reports significant jump in PBS benefits
October 21, 2020 - - Latest News -
ViiV Healthcare now looking to wider PBS listing
October 21, 2020 - - Latest News -
More calls for change from patient groups and companies
October 21, 2020 - - Latest News -
Are negotiations an opportunity to reset on patient input?
October 20, 2020 - - Comment -
Growth in immunoglobulin slows but still key driver
October 20, 2020 - - Latest News